ESSA Pharma Announces Overnight Marketed Equity Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
ESSA Pharma (EPIX) Prices Equity Offering at $0.20/Share
December 13, 2017 8:57 AM ESTESSA Pharma Inc. (NASDAQ: EPIX), a pharmaceutical company focused on the development of novel small molecule drugs for the treatment of prostate cancer, is pleased to announce today that the Company has priced its previously announced offering of equity securities (the "Offering"). Pursuant to the Offering, ESSA intends to issue common shares in the capital of the Company (the "Common Shares") at a price of US$0.20 per Common Share (the "Common Share Price").
The Offering will be undertaken on a best efforts basis pursuant to the terms and... More
ESSA Pharma (EPIX) Halted, News Pending
December 13, 2017 8:52 AM ESTESSA Pharma (NASDAQ: EPIX) Halted, News Pending
... More


